Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease.  Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens.

Growing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients. 

Biotechnology

Health Care

Therapeutics

Innoviva Specialty Therapeutics, Inc.

Steve Basso

Patricia Drake

David Altarac

Marianne Zhen

Marcie Cain

The Leadership Team at Innoviva Specialty Therapeutics, Inc. oversees the strategic direction and operation of the company, ensuring the successful development and delivery of innovative therapies for critical care and infectious diseases. This team provides critical guidance and makes high-level decisions to advance the company's mission, leveraging their expertise in finance, accounting, human resources, medical science, and research to address the urgent threat of antimicrobial resistance and improve patient outcomes.

Leadership Team

Director Team

Clinical Operations & Development

Critical Care Team

Leadership Team

About

Team members

Other teams at Innoviva Specialty Therapeutics, Inc.

Director Team

Clinical Operations & Development

Critical Care Team